Skip to content

Effect of local PRP injection on ovarian reserve and assisted reproductive outcomes: a randomized controlled study

Effect of local PRP injection on ovarian reserve and assisted reproductive outcomes: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057211
Enrollment
Unknown
Registered
2022-03-03
Start date
2022-03-04
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished Ovarian Reserve

Interventions

Intervention group:Injection of PRP
Control group:None

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. AFC =6 months without contraception; 3. The number of oocytes obtained by the previous standard regimen (antagonist and long regimen) was <=3; 4. The patient or his legal representative signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Hydrosalpinx: ultrasound or salpingography may indicate hydrosalpinx; 2. Adenomyosis: ultrasound /MRI diagnosis of adenomyosis with or without serum CA125 elevation; 3. Endometriosis: previous definite surgical diagnosis of endometriosis, or repeated ultrasound findings (>=3 times) of ovarian hypoecho; 4. Severe oligoasthenospermia/azoospermia; 5. Uterine malformations: unichorned uterus, bichorned uterus, mediastinal uterus; 6. Metabolic diseases: diabetes mellitus, hyperthyroidism, hypothyroidism untreated; 7. Obesity: BMI > 28; 8. Thin: BMI =3 or transfer embryos >=4; 10. Systemic diseases cannot tolerate IVF embryo transfer: serious cardiovascular and cerebrovascular diseases, blood system diseases and other organ diseases, whose specialist doctors do not recommend pregnancy; 11. Systemic diseases can not pregnancy: serious cardiovascular and cerebrovascular diseases, blood system diseases and other organ diseases, whose specialist doctors do not recommend pregnancy.

Design outcomes

Primary

MeasureTime frame
live birth rate;

Secondary

MeasureTime frame
number of eggs retrieved;2PN fertilization rate;available embryo rate;biochemical pregnancy rate;clinical pregnancy rate;ongoing pregnancy rate;miscarriage rate;embryo implantation rate;cycle cancellation rate;

Countries

China

Contacts

Public ContactWang Yanbin
iriswang0411@163.com+86 18611800160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026